Paula Hansen Sells 6,000 Shares of Docusign (NASDAQ:DOCU) Stock

Docusign Inc. (NASDAQ:DOCU) CRO Paula Hansen sold 6,000 shares of the company’s stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $45.54, for a total value of $273,240.00. Following the sale, the executive directly owned 89,972 shares of the company’s stock, valued at $4,097,324.88. The trade was a 6.25% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Docusign Stock Up 3.6%

Shares of NASDAQ:DOCU traded up $1.60 during trading on Wednesday, reaching $46.02. The stock had a trading volume of 3,492,477 shares, compared to its average volume of 4,953,224. The stock has a fifty day simple moving average of $46.93 and a two-hundred day simple moving average of $51.11. Docusign Inc. has a 52 week low of $40.16 and a 52 week high of $86.65. The firm has a market capitalization of $8.79 billion, a price-to-earnings ratio of 29.88, a P/E/G ratio of 1.31 and a beta of 0.90.

Docusign (NASDAQ:DOCU) last posted its quarterly earnings data on Thursday, June 4th. The company reported $1.09 EPS for the quarter, topping analysts’ consensus estimates of $0.99 by $0.10. Docusign had a return on equity of 17.48% and a net margin of 9.59%.The business had revenue of $830.24 million for the quarter, compared to analyst estimates of $824.71 million. During the same period in the previous year, the company posted $0.90 earnings per share. The firm’s revenue for the quarter was up 8.7% on a year-over-year basis. On average, analysts forecast that Docusign Inc. will post 2.03 EPS for the current year.

Docusign declared that its Board of Directors has initiated a share buyback program on Tuesday, March 17th that authorizes the company to buyback $2.00 billion in outstanding shares. This buyback authorization authorizes the company to buy up to 21% of its shares through open market purchases. Shares buyback programs are typically a sign that the company’s management believes its stock is undervalued.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the stock. Central Pacific Bank Trust Division acquired a new stake in shares of Docusign in the 4th quarter valued at $25,000. Modus Advisors LLC acquired a new stake in shares of Docusign during the fourth quarter worth approximately $27,000. Torren Management LLC bought a new position in shares of Docusign in the fourth quarter valued at approximately $28,000. True Wealth Design LLC boosted its holdings in shares of Docusign by 105.2% in the 4th quarter. True Wealth Design LLC now owns 433 shares of the company’s stock worth $30,000 after acquiring an additional 222 shares in the last quarter. Finally, Aventura Private Wealth LLC bought a new stake in Docusign during the 4th quarter worth approximately $30,000. 77.64% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on DOCU shares. Wall Street Zen raised shares of Docusign from a “buy” rating to a “strong-buy” rating in a research report on Saturday, June 13th. Citizens Jmp reduced their price objective on Docusign from $124.00 to $86.00 and set a “market outperform” rating for the company in a research report on Wednesday, March 18th. Robert W. Baird decreased their price objective on Docusign from $75.00 to $55.00 and set a “neutral” rating on the stock in a report on Wednesday, March 18th. Needham & Company LLC restated a “hold” rating on shares of Docusign in a research note on Friday, June 5th. Finally, BTIG Research decreased their price target on shares of Docusign from $70.00 to $60.00 and set a “buy” rating on the stock in a research note on Friday, June 5th. Three investment analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $60.27.

Docusign News Summary

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: Zacks Research raised its FY2027 EPS estimate for Docusign to $1.69 from $1.53, suggesting stronger expected profitability over the next couple of years.
• Positive Sentiment: The firm also increased its FY2028 EPS estimate to $1.76 from $1.89, and lifted Q1 2028 EPS to $0.47 from $0.45, reinforcing a more favorable near-to-midterm earnings view.
• Positive Sentiment: Analysts boosted Q4 2028 EPS to $0.62 from $0.59 and Q1 2029 EPS to $0.73 from $0.51, indicating continued expectation for earnings growth further out. Docusign estimate revisions
• Neutral Sentiment: Not all revisions were positive: Zacks trimmed Q2 2028 EPS to $0.28 from $0.43, Q3 2028 EPS to $0.38 from $0.41, and FY2029 EPS to $1.35 from $2.10, showing a mixed long-range outlook.
• Neutral Sentiment: The current-year consensus estimate remains around $1.97 per share, so the latest changes mainly affect longer-dated forecasts rather than near-term results.

Docusign Company Profile

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.